IonOpticks partners with Adelis to accelerate global expansion and innovation

IonOpticks responds to growing global market needs for proteomics tools by partnering with Nordic private equity firm

MELBOURNE, Australia and STOCKHOLM, Sept. 10, 2024 /PRNewswire/ -- IonOpticks, a leading global producer of high-performance chromatography columns, announces its partnership with Adelis Equity Partners ("Adelis"). The Nordic private equity firm is renowned for partnering with and accelerating the growth of companies in their focus sectors including healthcare and life sciences. The investment from Adelis will augment IonOpticks' global presence and drive innovation as the company expands closer to key markets and consolidates its leading position in the exciting and rapidly growing field of proteomics and adjacent applications.

The strategic partnership will enable IonOpticks to scale its operations globally, enhancing product development and better positioning the company to serve its growing customer base. Being closer to its customers and collaborators while also ensuring compatibility across major LC-MS platforms is a key priority, allowing researchers worldwide to benefit from IonOpticks' class-leading chromatography. Adelis' extensive experience, industrial advisor network and resources will support IonOpticks in maintaining its position as the provider of the best solutions for LC-MS proteomics research.

IonOpticks also strengthens its board with the appointment of several industry heavyweights, including Dr. Peter Wrighton-Smith as Chairman. With an established career in scaling life sciences companies, Peter is well-positioned to guide IonOpticks through its next phase of growth. Joining founders Xavier Perronnet and Dr. Jarrod Sandow, the board also welcomes industry leaders Mårten Winge, Sibel Arnes, and Rasmus Molander.

"I'm excited to join IonOpticks to help support the expansion of its commercialisation efforts globally and to help the company with its ambitious program of new product introductions into current and new markets." Dr. Peter Wrighton-Smith, newly appointed Chairman of IonOpticks, explains.

"We chose to partner with Adelis because they share our vision for IonOpticks' goals and are a strong cultural fit. Their genuine desire to work with us and guide the company to realise its goals, together with their experience, networks, and resources, made them the ideal partner. This partnership allows us to continue developing the best chromatography solutions for researchers worldwide and pursue further innovations tailored to the industry's evolving needs," says Xavier Perronnet, Chief Executive Officer of IonOpticks.

"Ultimately, it's about human health, and we believe that maximising what is discoverable in biological samples is a vital early step in developing therapies and improving patient outcomes. That's what IonOpticks does," Perronnet continues.

Director Sibel Arnes and Co-managing Partner Rasmus Molander at Adelis note, "Europe and indeed the Nordics has a long legacy in proteomics and pioneering human health research. When we met the team, we immediately recognised IonOpticks' unique solutions and global potential. Their commitment to working with key opinion leaders in the field and delivering best-in-class solutions is impressive, and the results from the accelerating research in proteomics is promising. IonOpticks aligns perfectly with Adelis' strategy of supporting unique and growing companies in healthcare and life sciences. It is a privilege to partner with a company that can meaningfully contribute to addressing many of our currently unresolved health conditions, and we look forward to collaborating with the IonOpticks team in the coming years."

IonOpticks' technology was developed at WEHI (Walter and Eliza Hall Institute of Medical Research) and the company was incubated at the institute for two years. "IonOpticks' evolution from its early-stage research and development to a global market presence, and now through this strategic partnership, underscores the value of supporting entrepreneurial scientists alongside executive leadership. It highlights the incredible potential of Australian life sciences innovations when backed by robust incubation and support," says Dr. Anne-Laure Puaux, Head of Business Development at WEHI.

About IonOpticks:
IonOpticks produces high-performance chromatography solutions for the global research community enhancing mass spectrometry (LC-MS) and high-end proteomics research. Their solutions enhance the sensitivity of mass spectrometry sample analysis, enabling scientists and clinicians to discover more from their samples. These advancements are valuable for a broad range of applications within the field of biological and medical research including drug discovery, phosphoproteomics and shotgun proteomics. https://ionopticks.com/

About Adelis Equity Partners

Adelis is a growth partner for well-positioned companies primarily in the Nordic and DACH regions. Adelis partners with management and/or owners to build businesses in growth segments with strong market positions. Since raising its first fund in 2013, Adelis has been one of the most active investors in the Nordic middle-market, making 42 platform investments and more than 230 add-on acquisitions. Adelis manages approximately €3.0 billion in capital. For more information, please visit www.adelisequity.com.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

IonOpticks partners with Adelis to accelerate global expansion and innovation

SINGAPORE, Sept. 17, 2024 /PRNewswire/ -- With translucent white light illuminating the stage and silk curtains drawn low, the twelve heroines of A Dream of Red Mansions gracefully swayed their way forward, leading the audience into a shared dream. As the performance concluded, actors took multiple bows amid continuous applause and cheers that lasted for over ten minutes. On the evening of September 13, original ethnic dance drama by Jiangsu Centre for the Performing Arts, A Dream of Red Mansions made a stunning international debut in Singapore. From September 13 to 15, the play was performed four times, sparking a new wave of interest in "Oriental Aesthetics" and successfully telling the story of Chinese culture. Cao Zhongming, China's ambassador to Singapore, attended the performance and went on stage afterward to express his appreciation and gratitude to the performers. He remarked, "A Dream of Red Mansions was a sold-out event in Singapore, reflecting the deep affection people have for this work. It also demonstrates that A Dream of Red Mansions has many admirers here in Singapore. This is a vivid example of the high-quality cultural exchanges between China and Singapore, and I believe it will further strengthen the bonds of cultural and human connections between the two countries."

The ethnic dance drama A Dream of Red Mansions was academically guided by the A Dream of Red Mansions Research Institute at the Chinese Academy of Arts, planned by Jiangsu Cultural Investment & Management Group Co., Ltd, presented by Willow Arts, produced by Jiangsu Centre for the Performing Arts, and co-produced by the Nanjing Ethnic Orchestra and Li Xing Studio. It draws deeply from the rich soil of traditional Chinese culture, using classical symbols and modern aesthetics to deconstruct, integrate, and reinterpret this timeless classic. Since its premiere in 2021, the production has toured 32 Chinese cities, with over 250 performances, creating a buzz where each show was sold out, and tickets were hard to come by.

With twelve heroines, twelve high-backed chairs, twelve small stools, twelve colors, and twelve bouquets of flowers, the production employs a rich vocabulary of dance, combined with music, stagecraft, lighting, and costume design to vividly depict iconic scenes such as the "Illusory Land of Great Void," "The Emperor's Consort Yuan Returns to Visit Her Family," and "Daiyu Buries the Flowers." The result is an artistic feast full of Oriental classical aesthetics, transporting the audience across time and space.

"The entire performance was captivating; it truly was a feast for the eyes and ears," remarked Low Eng Teong, Chairman of Singapore's National Arts Council. He felt that the unique interpretation of the drama vividly brought out the essence of A Dream of Red Mansions.

"I finally understand why some audience members come back to watch the same play multiple times," praised Sabrina Long, Dean of Faculty of Art & Design and Principal in School of Young Talents at Nanyang Academy of Fine Arts. She was deeply impressed by the performance, stating, "Every inch of detail on stage, every moment of the entire production, was captivating and mesmerizing. Every angle offers a new perspective, making each presentation unique. It is a deeply poetic work, and I was profoundly moved."

For some foreign audience members unfamiliar with the story of A Dream of Red Mansions, the dance drama not only allowed them to gain a deeper understanding of this classic but also gave them an unforgettable evening where they experienced the beauty and charm of Chinese culture.

"In Singapore, I rarely get to see performances like this, and I found it very interesting," said foreign audience member Mark. He admitted that he was previously unfamiliar with the background of A Dream of Red Mansions, adding, "What impressed me most today was the choreography of the group dances. I'm going to read up more about this Chinese story when I get home."

Wang Hongjun, Chairman of Jiangsu Cultural Investment & Management Group Co., Ltd, said, "Singapore has a strong cultural foundation, and through these two days of exchanges, we have seen a rising interest in A Dream of Red Mansions here. We hope that by staging this international performance, Singaporean audiences will have more opportunities to appreciate the beauty of traditional Chinese culture and to understand the innovative explorations and contemporary expressions that our young artists have infused into this work."

"We hope to bring this classic work to the international stage through the medium of dance drama, so that more people can appreciate the profoundness of Chinese traditional culture and to further promote cultural exchanges between China and Singapore," said Liao Yi, General Manager of Jiangsu Centre for the Performing Arts. He noted that the successful execution of A Dream of Red Mansions has allowed Jiangsu Centre for the Performing Arts to explore a path of collaborative production with multiple creative partners, with the ultimate goal of building a production-oriented performing arts center.

For this performance, an exhibition titled "Seeking Beauty in the Dream" showcasing the creative designs behind A Dream of Red Mansions, along with beautifully displayed costumes and cultural merchandise, was arranged outside the theater, drawing many audience members to stop by and take photos.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

The Spectacular Premiere of Jiangsu's Original Ethnic Dance Drama A Dream of Red Mansions in Singapore